The largest ever series of phage therapy case studies shows a success rate of more than half
The number of reported cases using viruses to treat deadly Mycobacterium infections just went up by a factor of five.
Jun 9, 2022
0
100
The number of reported cases using viruses to treat deadly Mycobacterium infections just went up by a factor of five.
Jun 9, 2022
0
100
For patients with infectious diseases like tuberculosis, timing is critical. Tuberculosis is one of the most common causes of death from a curable disease, and cases of drug-resistant tuberculosis are on the rise. But determining ...
Apr 5, 2012
0
0
(Medical Xpress)—The results of a phase 1/2 clinical trial in Europe of an investigational Lyme disease vaccine co-developed by researchers at Stony Brook University, Brookhaven National Laboratory, and at Baxter International ...
May 13, 2013
0
0
Antibiotic overuse and resistance have emerged as major threats during the past two decades. Following an outbreak of Clostridium difficile infections, which often result from antibiotic use, health care professionals in ...
Jul 26, 2011
0
0
Anne Neilan, MD, a physician-scientist in the division of Infectious Diseases at Massachusetts General Hospital is the senior author of a recently paper titled "Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who ...
Oct 12, 2023
0
1
A clinical trial has begun testing an experimental stem cell treatment against the best available biologic therapies for severe forms of relapsing multiple sclerosis (MS). The trial, sponsored by the National Institute of ...
Jan 7, 2020
0
21
Pre-exposure prophylaxis (PrEP), a combination drug used to prevent HIV infection, has already gained significant traction in the U.S. and Europe. The once-a-day pill, when taken consistently, can reduce the risk of HIV acquisition ...
May 10, 2019
0
1
Maybe you've never heard of the Epstein-Barr virus. But it knows all about you.
Oct 20, 2022
0
31
The University of Illinois at Chicago will soon test a vaccine for COVID-19.
Jun 15, 2020
0
4
Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after ...
Jul 13, 2020
0
18